These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6182740)

  • 1. Differentiation of amyloid fibril proteins in tissue sections. Two simple and reliable histological methods applied to fifty-one cases of systemic amyloidosis.
    Fujihara S
    Acta Pathol Jpn; 1982 Sep; 32(5):771-82. PubMed ID: 6182740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of monoclonal antibody against amyloid fibril protein and its immunohistochemical application.
    Kurashima C; Hirokawa K
    Appl Pathol; 1985; 3(1-2):39-54. PubMed ID: 3915946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method to classify amyloid fibril proteins.
    Kitamoto T; Tateishi J; Hikita K; Nagara H; Takeshita I
    Acta Neuropathol; 1985; 67(3-4):272-8. PubMed ID: 4050342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the protein components of amyloid using immunoperoxidase and permanganate methods on tissue sections.
    Looi LM
    Pathology; 1986 Jan; 18(1):137-40. PubMed ID: 2425332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
    Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
    Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
    van Rijswijk MH; van Heusden CW
    Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
    Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
    J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
    Bély M; Apáthy A
    Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis.
    Hoshii Y; Takahashi M; Ishihara T; Uchino F
    Pathol Int; 1994 May; 44(5):352-8. PubMed ID: 8044304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.
    Gorevic PD; Rodrigues MM; Krachmer JH; Green C; Fujihara S; Glenner GG
    Am J Ophthalmol; 1984 Aug; 98(2):216-24. PubMed ID: 6383050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of spontaneous amyloidosis of Syrian hamsters using the potassium permanganate method.
    Mezza LE; Quimby FW; Durham SK; Lewis RM
    Lab Anim Sci; 1984 Aug; 34(4):376-80. PubMed ID: 6482376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
    Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
    Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of different amyloid fibril proteins in tissue sections.
    Cornwell GG; Husby G; Westermark P; Natvig JB; Michaelsen TE; Skogen B
    Scand J Immunol; 1977; 6(11):1071-80. PubMed ID: 413186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histopathological diagnosis of amyloidosis].
    Hoshii Y
    Rinsho Byori; 2006 May; 54(5):513-8. PubMed ID: 16789423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.
    Sipe JD; Benson MD; Buxbaum JN; Ikeda SI; Merlini G; Saraiva MJ; Westermark P
    Amyloid; 2016 Dec; 23(4):209-213. PubMed ID: 27884064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.
    Wright JR; Calkins E; Humphrey RL
    Lab Invest; 1977 Mar; 36(3):274-81. PubMed ID: 839739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic amyloidosis: morphologic differences between systemic AL and AA types.
    Buck FS; Koss MN
    Hum Pathol; 1991 Sep; 22(9):904-7. PubMed ID: 1916751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström's macroglobulinemia associated with AA amyloidosis.
    Gardyn J; Schwartz A; Gal R; Lewinski U; Kristt D; Cohen AM
    Int J Hematol; 2001 Jul; 74(1):76-8. PubMed ID: 11530809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis.
    Looi LM; Sumithran E
    Hum Pathol; 1988 Jun; 19(6):732-5. PubMed ID: 2454214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cell dyscrasia in 105 Japanese patients with systemic amyloidosis.
    Isobe T; Tomita M; Matsumoto J; Fujita T
    Jpn J Med; 1983 Apr; 22(2):117-21. PubMed ID: 6865104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.